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	mediators determines the stable or progressive nature of periapical granulomas by 
modulating the balance of the osteoclastogenic factor RANKL and its antagonist OPG. 
However, the cytokine networks operating in the development of periapical lesions are quite 
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suggests. Here we simultaneously investigated the patterns of Th1, Th2, Th9, Th17, Th22, 
Thf, Tr1 and Tregs cytokines/markers expression in human periapical granulomas. Methods: 
The expression of TNF-α, IFN-γ, IL-17A, IL23, IL21, IL-33, IL-10, IL-4, IL-9, IL-22, FOXp3 
markers (via RealTimePCR array) was accessed in active/progressive (N=40) versus 
inactive/stable (N=70) periapical granulomas (as determined by RANKL/OPG expression 
ratio), and also to compare these samples with a panel of control specimens (N=26). A 
cluster analysis of 13 cytokine levels was performed to examine possible clustering between 
the cytokines in a total of 110 granulomas. Results: The expression of all target cytokines 
was higher in the granulomas than in control samples. TNF-α, IFN-γ, IL-17A and IL-21 mRNA 
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levels of IL-4, IL-9, IL-10, IL-22 and FOXp3 were higher than in active granulomas. Five 
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inactive and active periapical lesions. While the widespread cytokine expression seems to 
be a feature of chronic lesions, hierarchical cluster analysis demonstrates the association 
of TNF-α, IL-21, IL-17 and IFN-γ with lesions activity, and the association of FOXP3, IL-10, 
IL-9, IL-4 and IL-22 with lesions inactivity.
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INTRODUCTION
Periapical lesions triggered by bacterial 
infection of pulpal and endodontic environment 
are characterized by the destruction of mineralized 
tissues surrounding the root apex as a consequence 
of the local host response19. In this context, 
cytokines play a major role in the modulation 
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periapical microenvironment, and, therefore, 
are critical determinants of lesions outcome12,19. 
Previous studies demonstrate that the balance 
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determines the stable or progressive nature of 
periapical granulomas by modulating the balance 
of the osteoclastogenic factor RANKL and its 
antagonist OPG12,29. However, the cytokine networks 
operating in the development of periapical lesions 
are quite more complex than what the relatively 
simple 	 	 
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paradigm could suggest5, being the pathogenesis of 
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other cytokine classes12,19.
In this scenario, Th1 cytokines (IFN-γ, IL-12) 
have been associated with bone destruction and 
lesion progression, while its classic Th2 antagonists 
(IL-4, IL-10, and the recently described IL-33) are 
described to limit or attenuate the tissue damage19. 
Beyond the Th1/Th2 archetype, Th17 cells emerged 
as a T subset with inflammatory properties 
involved in a series of infectious, autoimmune 
and osteolytic processes41. While the prototypical 
Th17 cytokine is IL-17, Th17 cells can also produce 
other effector cytokines with osteoclastogenic 
properties, such as IL-6 and IL-23, reinforcing 
the potential destructive role of Th17 subset in 
periapical lesions41. On the other hand, regulatory 
T cells (Tregs, a FOXp3+CD4+ subset) and Tr1 
cells present		VV
		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
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osteolysis, thought to be mediated by cytokines 
such as TGF-β and IL-103,15,17. Interestingly, the 
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the outcome of periapical lesions9,28.
Adding more complexity to the cytokine network 
in periapical lesions, Th9 and Th22 cytokines are 
expressed in human and experimental periapical 
lesions, where they are supposed to contribute to 
lesion stability1. IL-9 (the main Th9 product) and 
IL-22 (the Th22 signature cytokine) have been 
described as pleiotropic cytokines, whose pro- or 
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depending on the overall cytokine milieu5. Other 
pleiotropic cytokines, such as IL-21 (a product of 
Th17 or T follicular helper [Tfh] cells), can also 
impact the overall immunoregulatory milieu, and 
also the osteoclastogenesis and bone resorption 
processes25.
While previous studies describe the possible 
involvement of the mentioned cytokines in periapical 
lesions as a general rule, such mediators’ expression 
have been investigated independently or in small 
sets6,19,28, which does not provide a reasonable 
understanding of the whole cytokine network in 
periapical environment. Indeed, considering the 
notable interplay between the cytokines5, only the 
simultaneous analysis of a broad cytokine panel can 
provide a picture of the overall immunoregulatory 
scenario operating at periapical lesions. Therefore, 
here we simultaneously investigated the patterns 
of Th1, Th2, Th9, Th17, Th22, Thf, Tr1 and 
Tregs cytokines/markers expression in human 
chronic periapical granulomas and their possible 
correlations with lesions activity pattern.
MATERIAL AND METHODS
Samples
This study had institutional review board approval 
of Bauru School of Dentistry, University of São Paulo. 
Patients presenting periapical lesions were referred 
to endodontic surgery after conventional root canal 
treatment failure; periapical lesions diagnosis was 
performed as previously described29,30, based on 
histopathological and radiographic analysis, being 
periapical lesions characterized radiographically as 
rarefaction lesions with the disappearance of the 
periodontal ligament space and discontinuity of the 
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presence of periradicular radiolucency that did not 
resolve, persisting as before acceptable endodontic 
treatment (i.e. having all canals instrumented and 
obturated, with no voids in the obturation mass, 
the apical terminus of the obturation at 1/1.5 mm 
from the radiographic apex), or that increased in 
size with evidences of continuous bone resorption2. 
Periapical granulomas (N=110) were collected from 
patients (N=110, aged 19-59; 51 females and 59 
males) during periapical surgery and divided in 
two roughly similar fragments and stored in both 
formalin (for routine histological examination; 
was performed after hematoxylin-eosin staining) 
and RNAlater (Ambion, Austin, TX) (for molecular 
analysis) solutions. Test samples were limited 
to granulomas, histopathologically defined by 
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macrophages, and without the presence of an 
epithelial lining. Periapical cysts, where cavities 
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squamous epithelium, and partially epithelized 
lesions (epithelized granulomas) were excluded 
from the study. Patients with medical conditions 
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metabolism or other assisted drug therapy (i.e. 

	

	

		
hormonal therapy) during the last 6 months before 
the study were excluded. Patients with preexisting 
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conditions, such as periodontal disease, and 
pregnant or lactating women were also excluded. 
Healthy periodontal ligament tissue samples (N=26) 
obtained from premolars extracted for orthodontic 
purposes (patients aged 19-24 years, 12 females 
and 14 males) and stored in RNA later were used 
as control specimens. Lesions were also categorized 
into putative active (A) and inactive (I), based in the 
		V	DEJ$^?~	DJE		
as previously described29.
RNA extraction and RealTime-PCR reactions
Samples were submitted to molecular analyses 
as previously described30. In brief, total RNA was 
extracted from samples by using the RNeasy 
kit (Qiagen Inc, Valencia, CA) according to the 
manufacturers’ instructions. The integrity of RNA 
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RNA on 2100 Bioanalyzer (Agilent Technologies, 
Santa Clara, CA) according to the manufacturers’ 
instructions. After RNA extraction, complementary 
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a reverse transcription reaction using QuantiTectRT 
kit (Qiagen Inc, Valencia, CA). All cytokines/Th 
markers (TNF-α, IFN-γ, IL-17A, IL-23, IL-21, IL-
33, IL-10, IL-4, IL-9, IL-22, FOXp3) mRNA levels 
were measured by means of RealTimePCR using 
TaqMan chemistry (Invitrogen, Carlsbad, CA) in a 
Viia7 instrument (LifeTechnologies, Carlsbad, CA) 
using inventoried optimized primers/probes sets 
(Invitrogen, Carlsbad, CA), with basic reaction 
conditions (40 cycles) at 95°C (10’), 94oC (1’), 56°C 
(1’) and 72°C (2’). The analysis of RANKL and OPG 
mRNA levels were also determined in all the lesions 
(also by RealTimePCR using TaqMan chemistry), 
in order to categorize each sample in putative 
active and inactive lesions based on the RANKL/
OPG ratio as previously described29. The results are 
depicted as the relative level of gene expression; 
calculated in reference to internal controls GAPDH 
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2-DDCt method2,16.
Data analysis
Cytokine expression data is presented as 
a mean of mRNA expression, normalized by 
reference to the housekeeping genes from triplicate 
measurements in each sample. Comparisons 
among controls, inactive and active lesions were 
performed by ANOVA followed by Bonferroni 
post-test (performed in GraphPad Prism5.0 
software, GraphPad Software Inc, San Diego, CA, 
USA); being p<0.05 was considered statistically 
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between the cytokines, a cluster analysis of 13 
cytokine levels in 110 periapical granulomas was 
performed by using the Spearman rank correlation 
V
		
	$W%	#$%5	

44. After 
clusters determination, a hierarchical analysis was 
performed to access cytokine clusters association 
with activity/inactivity status, considering 1) the 
degree of lesion activity, ranked from inactivity-
to-activity based in the RANKL/OPG ratio, ranging 
from 0.43 to 4.46, in accordance with the initially 
defined clusters; 2) the variance in individual 
cytokine expression levels within all 8 clusters were 
analyzed from the statistical viewpoint in order to 
generate a heat-like map representing the relative 
levels of expression (i.e. clusters with relative low 
levels are represented by the color white, clusters 
with relatively homogenous expression levels are 
represented by the color yellow, and clusters with 
increased gene expression are depicted in red; 
comprising a 6 grade scale representative of 16.66% 
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ranking step the cytokines were ordered based in 
the cumulative frequency of high/intermediate/low 
levels along the inactive/active poles.
RESULTS
The pattern of cytokine expression in active 
and inactive granulomas
The mRNA levels expression of all targets 
investigated was found to be higher in total 
periapical granulomas when compared to controls 
(Figure 1). When lesions were compared based in 
the RANKL/OPG expression pattern29, 40 samples 
were found to be active (RANKL>OPG), while 70 
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(Figure 1). When active and inactive lesions were 
compared, TNF-α, IFN-γ, IL-17A and IL-21 mRNA 
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(Figure 1), while in inactive lesions the expression 
levels of IL-4, IL-9, IL-10, IL-22 and FOXp3 were 
higher than in active granulomas (Figure 1). The 
levels of IL-23 and IL-33 in active and inactive 
lesions were similar from a statistical viewpoint 
(Figure 1).
Cluster and hierarchical analyzes of cytokine 
association with active and inactive lesions
In the view of the distinctly divergent cytokine 
profile between controls and lesions, cluster 
analysis was only performed with the lesion data 
in order to avoid biased associations. Initial cluster 
analysis performed with all (active + inactive) the 
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major clusters, comprised by 41 and 69 samples, 
presenting a 98% match with the clustering based 
in the RANKL/OPG patterns29. Considering such 
clear dichotomy, we performed additional cluster 
analysis within active and inactive lesions groups. 
In inactive lesions group (Table 1), 5 clusters were 
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Figure 1 - Expression of individual mRNAs, with normalization to housekeeping genes, in periapical granulomas. Total RNA 
was extracted from periapical granulomas (experimental groups, N=110) and periodontal ligament (control group, N=26), 
and levels of RANKL and OPG mRNA were measured quantitatively by RealTimePCR using TaqMan chemistry. Based in 
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between controls and periapical lesions (active + inactive)
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the clusters of inactive lesions, while IL-22, OPG, 
IL-23, TNF-α, RANKL and IL-21 levels presented 
KW p values higher than 0.05. When active lesions 
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being the variance in the expression levels of IL-
22, IL-10, IFN-γ, IL-17, IL-33, FOXp3, IL-21 and 
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the active lesions clusters, while IL-9, IL-4, TNF-α, 
OPG and IL-23 levels presented KW p values higher 
than 0.05.
The subsequent hierarchical analysis (Table 3 
and Figure 3) ordered the samples regarding the 
activity level, from inactivity to activity ends, and 
demonstrated that inactivity pole was characterized 
by the highest OPG levels, sequentially followed 
in a downward way by FOXp3, IL-10, IL-9, IL-4 
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relatively stable within inactive clusters; FOXP3 and 
IL-10 levels prevail in the clusters located in the 
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hand, the lesion activity pole was characterized by 
the highest expression of TNF-α, downward followed 
by RANKL, IL-21, IL-17 and IFN-γ (Table 3 and 
Figure 3). High levels of TNF-α expression were a 
hallmark of all active clusters, RANKL expression 
prevails in the clusters located in the activity pole 
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clusters within active lesions (Table 3 and Figure 
3). Interestingly, one cluster from inactive lesions 
subset presented a relatively high expression of 
IL-17. In an intermediate level within inactivity and 
activity poles, the cytokines IL-23 and IL-33 were 
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(Table 3 and Figure 3).
DISCUSSION
Regulatory molecules such as cytokines play a 
key role in the pathogenesis periapical lesions12,19. 
Since the fragmented analysis of Th1, Th17, Th2, 
Th9, Th22 and Tregs related cytokines/markers 
expression suggests its involvement in periapical 
lesion development, but do not allow the analysis of 
the overall cytokine network operating in periapical 
environment; in this study we simultaneously 
investigated the patterns of such factors expression 
in active and inactive periapical lesions, as well the 
possible existence of cytokine clusters that could 
account for lesions outcome.
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in periapical lesions was compared with healthy 
control tissues, the expression of all cytokines/
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augmented in the lesions, in accordance with 
previous studies1,6,9,10,19. In a general context, the 
widespread cytokine expression in the lesions is 
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to the unremitting infection in the root canal 
and periapical area12,19. While the dichotomous 
Figure 2- Patterns of cytokine expression in active and 
inactive periapical granulomas. Total RNA was extracted 
from periapical granulomas (N=110) and periodontal 
ligament control samples (N=26), and levels of TNF-
α# Y]JJJ? ?^%< _Y`V #j !
Tr1 marker), IFN-γ (Th1 marker), IL-4 (Th2 marker), FOXp3 
(Treg marker), CTLA4 (Treg marker), TGF-β (Treg and 
Th3 marker), IL-9 (Th9 marker), IL-17A (Th17 marker), 
IL-17F (Th17 marker), IL-21 (Th17 or Tfh marker), IL-23 
(Th17 marker) and IL-22 (Th22 marker) were measured 
quantitatively by RealTimePCR using TaqMan chemistry. 
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comparison between health and disease conditions 
can be fairly revealing, it does not provide a disease 
severity and activity gradient, limiting the strength 
of such data to support more robust hypotheses. 
However, the comparison between active and 
inactive lesions29,48 provides a better picture of 
clinical variance, and therefore provide the support 
necessary to more robust analyses.
Initially, considering the active lesions scenario, 
the expression of TNF-α, IFN-γ, IL-17 and IL-21 
prevail in these lesions. TNF-α is classically described 
as a pro-inflammatory and osteoclastogenic 
cytokine13,18. Indeed, TNF-α 		V	
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lesions, being its involvement in experimental 
periapical lesions progression clearly demonstrated 
in a cause-effect experiments18. Our data also 
demonstrated that the Th1-signature cytokine 
IFN-g was highly expressed in active lesions. While 
IFN-g is described to inhibit osteoclastogenesis in 
inactive C1 inactive C2 inactive C3 inactive C4 inactive C5 KW p ANOVA p
IL-17 4.10±1.34 2.60±1.00 4.98±0.91 2.70±1.11 1.75±0.79 0.00000 0.00000 
IL-10 3.07±1.90 5.79±1.60 3.82±1.30 2.12±0.74 2.16±1.11 0.00000 0.00000 
FOXp3 3.46±2.47 4.36±1.32 2.42±0.66 2.10±0.83 2.53±1.07 0.00000 0.00000 
IFN 2.75±1.48 2.76±0.95 1.93±0.68 3.03±0.52 5.58±1.96 0.00000 0.00000 
IL-9 3.03±1.88 3.45±0.80 2.69±1.15 4.21±0.97 1.84±0.86 0.00011 0.00000 
IL-33 2.24±0.52 3.70±1.32 3.54±1.48 4.84±1.26 3.53±1.30 0.00157 0.00146 
IL4 2.03±0.71 3.13±1.31 1.97±0.75 2.76±1.12 3.81±0.84 0.00252 0.00244 
IL-22 4.18±1.11 2.94±0.88 3.07±0.60 2.58±1.02 2.78±0.92 0.09754 0.01919 
OPG 1.07±0.54 0.78±0.41 0.93±0.49 0.80±0.41 0.60±0.26 0.40770 0.27883 
IL-23 2.15±0.97 2.64±0.93 2.12±0.74 2.68±0.85 2.48±1.01 0.42409 0.40102 
TNFα 1.91±0.55 2.59±0.98 2.92±0.68 2.56±1.49 2.61±1.42 0.49012 0.60985 
RANKL 0.47±0.39 0.38±0.18 0.47±0.29 0.43±0.18 0.57±0.34 0.76167 0.36040 
IL21 2.31±0.96 3.03±1.88 2.90±1.35 3.07±1.57 2.39±1.10 0.89569 0.73603
N 5 27 11 18 9 nd nd
Table 1-~"Q#`YW%!!"Q<>""	
IL-17, IL-10, FOXp3, IFN-γ<_Y<_Y!_Y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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IL-23, TNF-α, RANKL and IL-21 levels presented KW p values higher than 0.05
active C1 active C2 active C3 KW p ANOVA p
IL-22 1.13±0.30 3.30±0.79 1.45±0.77 0.00007 0.00000 
IL-10 1.71±0.44 2.36±0.61 3.10±0.98 0.00022 0.00001 
IFN 5.72±1.43 3.62±2.41 8.02±1.84 0.00029 0.00002 
IL-17 4.74±1.74 5.54±0.75 3.14±0.92 0.00073 0.00111 
IL-33 3.85±1.18 1.88±1.25 2.80±1.19 0.00135 0.00069 
FOXp3 1.98±1.04 3.08±1.51 3.55±1.68 0.01007 0.00902 
IL21 3.88±2.48 6.07±2.49 5.91±1.09 0.01426 0.01684 
RANKL 1.43±0.65 1.16±0.44 0.86±0.35 0.03475 0.02563 
IL-9 1.73±0.77 1.80±0.58 2.60±1.12 0.05429 0.02585 
IL4 2.31±1.14 1.48±0.47 2.36±1.16 0.15877 0.10883 
TNFα 4.34±1.80 3.76±1.97 3.63±1.56 0.40797 0.50789 
OPG 0.32±0.23 0.36±0.16 0.30±0.19 0.55426 0.77663 
IL-23 2.74±0.88 2.57±1.52 2.60±1.27 0.68514 0.91416
N 20 9 11 nd nd
Table 2-jQ#`Y%!!"Q<>""	
IL-22, IL-10, IFN-γ<_Y`<_Y<~<_Y`!
?#'V*VW%JQ<
IL-9, IL-4, TNF-α, OPG and IL-23 levels presented KW p values higher than 0.05
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vitro, a clear association with increased bone loss 
is described in vivo, where the upregulation of 
TNF-α, IL-1β and RANKL overcome the direct anti-
osteoclastogenic effect described in vitro11,14,22,34,35. 
Regarding periapical lesions, IFN-γ positive cells 
are found in both periapical granulomas and 
cysts, where they are supposed to be involved in 
periapical lesion development6. Additionally, the 
Th17-prototytical cytokine IL-17A, described as a 


	 
	 osteoclastogenic factor, 
was also found in higher levels in active periapical 
lesions where it is supposed to exacerbate the 

	 

	 7,28,33,41. The last 
cytokine found to be overexpressed in active lesions 
is IL-21, a cytokine produced by Th17 and Tfh cells 
previously implicated in osteoclastogenesis and 
bone destruction8,24. Tfh, a CD4+ Tcell subset found 
in the B-cell follicles of secondary (and feasibly 
tertiary) lymphoid organs27, is described as a major 
contributor to B cell-mediated antibody responses 
and an important source of IL-2143. Considering 
the chronic nature of periapical lesions and the 
abundant presence of B cells in such environment26, 
it would be possible to suggest that IL-21 in 
periapical area contributes to a Thf-B cell response 
axis, similarly to what was described in tertiary 
lymphoid tissues associated with chronic infection 
sites20,47. Since B cells are described as a potential 
RANKL source12,19, Thf-B cell axis can directly drive 
lesions activity via RANKL production.
Taken together, the discussed evidences suggest 
a role of TNF-α, IFN-γ, IL-17A and IL-21 in the 
periapical lesions progression. In order to clarify 
the possible interplays between such cytokines, 
cluster hierarchical analyses were performed and 
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
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
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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lesions subset. The maximum activity (i.e. higher 
RANKL/OPG ratio) cluster (active cluster 1) was 
characterized by the highest TNF-α and RANKL 
levels among active lesions, and relatively high 
IL-21, IL-17 and IFN-γ expression. In this high 
activity scenario, it is possible to suggest that local 
TNF-α 	B;	

	V	
	

		
activity of both Th1 and Th17 cells, as previously 
described in experimental arthritis32. Accordingly, 
when mice strains with opposing bone resorption 
susceptibility phenotypes were compared, parallel 
high levels of TNF-α and IFN-γ were associated with 
increased bone resorption activity45,46. However, a 
negative correlation between the relatively high 
levels of both IFN-γ and IL-17 was observed in all 
the active lesion clusters. Indeed, active cluster 2 
was characterized by the highest levels of IL-21 
and IL-17, while the active cluster 3 presented the 
highest IFN-g levels and a high IL-21 expression. 
Therefore, Th1- (active cluster 3) and Th17- (active 
cluster 2) biased clusters were evidenced within 
active clusters. Accordingly, previous studies 
demonstrate a reciprocal Th1/Th17 inhibition, 
suggesting that Th1 and Th17 mediators may be 
independently associated to the progression of 

	 

	 4. It is essential 
to consider that the hierarchical analysis points 
to Th1-biased cluster (active cluster 3) as lower 
activity cluster than the clusters with high Th17 
activity (active clusters 1 and 2). Accordingly, while 
literature seems to present a relative consensus 
regarding the osteoclastogenic role of IL-17/Th17, 
the association of IFN-γ/Th1 with bone resorption 
process remains quite controversial12,19. Regarding 
IL-21, the levels of such cytokine were found to be 
elevated in both Th1- and Th17-biased clusters, 
but no direct positive/negative correlations were 
observed, suggesting that Tfh cells may operate in 
parallel (or even cooperatively) with both Th1 and 
Th17 mediators.
%&'*+<	=	=+='+	=	>+?%<@@+	==	=DHH			
	H<@		@'
>'<	*	D<+	
	+HD	
	?H<@	?*
Table 3- Hierarchical analysis ordering the samples regarding the activity level, from inactivity to activity ends based on 
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Figure 3- Patterns of cytokine expression in the clusters associated with active and inactive periapical granulomas nature. 
Hierarchical analysis demonstrated that the inactivity pole was characterized by the highest OPG levels, sequentially 
	! 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!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stable within inactive clusters; FOXP3 and IL-10 levels prevail in the clusters located in the inactivity pole edge, while a 
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pole was characterized by the highest expression of TNF-α, downward followed by RANKL, IL-21, IL-17 and IFN-γ. High 
levels of TNF-α expression were a hallmark of all active clusters, and RANKL expression prevail in the clusters located in 
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"?!X<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within active lesions. Interestingly, one cluster from inactive lesions subset, presented a relatively high expression of IL-17. 
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Moving the focus towards the putative 
determinants of lesions inactivity, IL-4, FOXp3, IL-
10, IL-9 and IL-22 levels in inactive lesions overcome 
the levels observed in active sites. IL-4 represents 
the prototypic Th2 cytokine, being a potential 
protective mediator due its ability to upregulate 
OPG levels and suppress pro-inflammatory 
responses40. Besides IL-4, IL-33 also has been 
associated with Th2 responses and presents similar 
properties towards bone protective action, such 
as the inhibition of osteoclast differentiation39. 
Along Th2 responses, Tregs (characterized by the 
expression of FOXp3) and Tr1 cells are supposed 
to attenuate periapical lesions development6,9. 
Indeed, IL-10 (a characteristic product of both 
Tregs and Tr1 subsets) was previously detected in 
	 		 
	 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30,38. While the 
positive correlations observed between IL-10 
and FOXp3 levels in inactive lesions reinforce 


	8				
		V	;'		
		
	W	V	
	8;	W	
does not allow stronger assumptions regarding 
its possible involvement in this system. Besides 
IL-4 and IL-10, IL-9 and IL-22 were found to be 
overexpressed in inactive lesions, in accordance 
with previous data1. Th9 cells have been described 
to present an interesting plasticity, acting together 
with Th2 in some inflammatory processes or 
exerting immunosuppressive actions via IL-10 
production42. IL-22 is also highly pleiotropic, since 
it can cooperate with IL-10 in a regulatory network 
that reduces the severity of experimental arthritis37 
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as TNF-α of IL-1749.
When potentially protective mediators associated 
with periapical lesions inactivity are scrutinized 
by the cluster hierarchical analysis, 5 distinct 
clusters were observed. The lowest activity pole 
is comprised by a cluster (inactive cluster 1) 
presenting the highest levels of OPG and IL-22, 
in parallel with relatively high levels of IL-10 and 
FOXP3 (the Tregs hallmark), comprising therefore 
a Th22/Tregs-biased cluster. While IL-22 can be a 
product of Th17 cells and operates in concert with 
;<		
		
	51, 
recent evidences demonstrate that when produced 
by Th22 cells in an milieu with low IL-17 levels 
#		
		
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BB	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mediated immunosuppressive effects31. Also, since 
Tregs are able to suppress Th17/IL-17-mediated 
responses50, it is possible to suggest that Tregs 
favor IL-22/IL-10 axis via Th17 suppression. The 
subsequent cluster in a presumed ascending activity 
level (inactive cluster 2) is characterized by the 
highest levels of FOXp3 and IL-10, along relatively 
high levels of both IL-4 and IL-9; typifying a Treg/
Tr1-biased cluster. The classic description of Tregs 
	8;	 	 	 
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previously discussed, and supports the dominance 
of Tregs and Tr1 in determining such cluster 
inactivity via IL-10 production. Interestingly, it 
was recently demonstrated that the presence of 
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IL-2221, which could account for the relatively low 
levels of IL-22 observed in this cluster. While such 
association contradicts the hypothesis of the Th22/
Tregs- cluster previously discussed, we can consider 
that the relatively high IL-4 and IL-9 levels may be a 
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Indeed, both Th2 responses (via Th2-chemokine 
CCL22 mediated Tregs chemoattraction) and IL-10 
can contribute to the immunosuppressive response 
via IL-1017,42.
The next inactive lesions cluster (inactive cluster 
3) is characterized by a high IL-10 expression, 
relatively low FOXp3, IL-4 and IL-9 levels, and a 
singular high IL-17 expression. Initially considering 
the lack of a direct correlation/association between 
FOXp3 levels and IL-10, it is possible to hypothesize 
a dominant role for Tr1 instead of classic FOXp3+ 
Tregs in this cluster. Indeed, the high levels of IL-
17 in parallel with the low levels of FOXp3 may 
be representative of a plastic behavior of Th17/
Tregs cells, where environmental signals can 
limit Tregs suppressive activity52. Following the 
clusters ascending activity level, the subsequent 
cluster (inactive cluster 4) is characterized by the 
highest IL-9 and IL-33 levels. Since no evidences 
of collaborative actions between IL-33 and IL-9 are 
reported, it is reasonable to consider that these T 
cell subsets may exert independent roles in the 
determination of lesions inactivity. While the data 
regarding IL-9 and bone lytic process is scarce 
as previously discussed, its possible association 
with lesions inactivity relies on the possible 
association with IL-10 production1,42. Considering 
the potential protective role of IL-33, while its anti-
osteoclastogenic action was recently described23, 
IL-33 levels are similar in overall inactive/active 
lesions, weakening the hypothesis that IL-33 plays 
a major role as a determinant of periapical lesions 
inactivity.
Finally, in the edge between inactive and active 
lesion clusters, a Th2-biased cluster (inactive 
cluster 5) is characterized by the highest IL-4 levels 
within inactive lesions. IL-4 is usually described to 
limit or attenuate the tissue damage due its anti-

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 inhibition 
of RANKL, concomitantly with OPG upregulation36, 
and the 	V	
		8;
type responses6,19,35. Recently, it was described 
that the Th2-type chemokine CCL22 (which can 
be induced by IL-4) attenuates periodontal lesions 
severity though Tregs chemoattraction17. However, 
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the relatively low levels of FOXp3 and IL-10 in this 
Th2 biased cluster, as well as the lack of negative 
correlations between IL-4 and IFN-g does not 
support such hypotheses. These results suggest 
that a dominant IL-4 response, in parallel to low 
levels of other potentially protective cytokines, 
may not be highly effective in determining lesions 
inactivity. Indeed, this IL-4-biased cluster is located 
in the frontier between inactive and active lesions, 
being its RANKL/OPG ratio roughly 2 times higher 
than the other 4 inactive clusters.
Taken together, our results demonstrate distinct 
patterns of cytokine expression in active and 
inactive periapical granulomas. In active lesions, 

	8;		8;<	W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concert with IL-21 are supposed to independently 
drive lesions progression. Conversely, inactive 
lesions present a more complex scenario, were 
Th22/Tregs, Tregs/Tr1, Tr1, Th9 and Th2 biased 
clusters can account for lesion inactivity status. 
However, further cause-and-effect studies are 
required to fully dissect the cytokine network 
involved in the pathogenesis of periapical lesions, 
aiming to unravel the protective and destructive 
pathways and therefore contribute to improve 
the diagnosis and treatment of these pathologies. 
However, further studies are required to support 
our hypothesis.
CONCLUSION
E		
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	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expression in inactive and active periapical lesions. 
While the widespread cytokine expression seems 
to be a feature of such chronic lesions, hierarchical 
cluster analysis demonstrates the association of 
TNF-α, IL-21, IL-17 and IFN-γ (ordered by their 
supposed destructive potential) with lesions’ 
activity, and the association of FOXp3, IL-10, IL-9, 
IL-4 and IL-22 (ordered in its supposed protective 
potential) with lesions’ inactivity.
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